The HPA Axis and the Immune System. A Perspective

NeuroImmune Biology

Volumn 7, Issue C, 2007, Pages 3-15

  Dunn, Adrian J ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957042588     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)00201-3     Document Type: Review

References (87)

1. Blalock J.E. The immune system as a sensory organ. J Immunol 132 (1984) 1067-1070
2. Blalock J.E., and Smith E.M. Conceptual development of the immune system as a sixth sense. Brain Behav Immun 21 (2007) 23-33
3. Claman H.N. Corticosteroids and lymphoid cells. N Eng J Med 287 (1972) 388-397
4. De Bosscher K., Vanden Berghe W., and Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 109 (2000) 16-22
5. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (1995) 286-290
6. Besedovsky H.O., and del Rey A. Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun 21 (2007) 34-44
7. Besedovsky H.O., del Rey A., Sorkin E., and Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 (1986) 652-654
8. Besedovsky H.O., and del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17 (1996) 64-102
9. Turnbull A.V., and Rivier C. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79 (1999) 1-71
10. Dunn A.J. Cytokine activation of the HPA axis. Ann NY Acad Sci 917 (2000) 608-617
11. Dunn A.J. Cytokine activation of the hypothalamo-pituitary-adrenal axis. In: Steckler T., Kalin N., and Reul J.M.H.M. (Eds). Handbook of Stress and the Brain Part 2: Stress: Integrative and Clincial Aspects (2005), Elsevier, Amsterdam 157-174
12. Ericsson A., Ek M., Wahlstrom I., Kovacs K., Liu C., Hart R., et al. Pathways and mechanisms for interleukin-1 mediated regulation of the hypothalamo-pituitary-adrenal axis. In: McCarty R., Aguilera G., Sabban E., and Kvetnansky R. (Eds). Stress: Molecular Genetic and Neurobiological Advances (1996), Gordon and Breach Science Publishers, New York 101-120
13. Dunn A.J. Mechanisms by which cytokines signal the brain. In: Clow A., and Hucklebridge F. (Eds). Neurobiology of the Immune System, International Review of Neurobiology (2002), Academic Press, San Diego 43-65
14. Katsuura G., Arimura A., Koves K., and Gottschall P.E. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1β-induced ACTH release. Am J Physiol 258 (1990) E163-E171
15. Blatteis C.M., and Sehic E. Fever: how may circulating pyrogens signal the brain. News Physiol Sci 12 (1997) 1-9
16. Goehler L.E., Erisir A., and Gaykema R. Neural-immune interface in the rat area postrema. Neuroscience 140 (2006) 1415-1434
17. Banks W.A., Kastin A.J., and Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2 (1995) 241-248
18. Banks W.A., Farr S.A., La Scola M.E., and Morley J.E. Intravenous human interleukin-1α impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 299 (2001) 1-6
19. Watkins L.R., Maier S.F., and Goehler L.E. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci 57 (1995) 1011-1026
20. Goehler L.E., Gaykema R., Hansen M.K., Anderson K., Maier S.F., and Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci 85 (2000) 49-59
21. Fleshner M., Goehler L.E., Hermann J., Relton J.K., Maier S.F., and Watkins L.R. Interleukin-1β induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull 37 6 (1995) 605-610
22. Wieczorek M., and Dunn A.J. Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats. Brain Res 1101 (2006) 73-84
23. Fleshner M., Goehler L.E., Schwartz B.A., McGorry M., Martin D., Maier S.F., et al. Thermogenic and corticosterone responses to intravenous cytokines (IL-1β and TNF-α) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol 86 (1998) 134-141
24. Quan N., Whiteside M., and Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res 802 (1998) 189-197
25. Cao C., Matsumura K., Yamagata K., and Watanabe Y. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am J Physiol 282 (1997) R1712-R1725
26. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26 (2001) 761-788
27. Quan N., Stern E.L., Whiteside M.B., and Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 93 (1999) 72-80
28. Roh M.S., Drazenovich K.A., Barbose J.J., Dinarello C.A., and Cobb C.F. Direct stimulation of the adrenal cortex by interleukin. Surgery 1 (1987) 140-146
29. Gwosdow A.R., Kumar M., and Bode H.H. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis. Am J Physiol 258 (1990) E65-E70
30. Cambronero J.C., Rivas F.J., Borrell J., and Guaza C. Is the adrenal cortex a putative site for the action of interleukin-1. Horm Metab Res 24 (1992) 48-49
31. Dunn A.J. Role of cytokines in infection-induced stress. Ann N Y Acad Sci 697 (1993) 189-202
32. Berkenbosch F., van Oers J., del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-526
33. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
34. Uehara A., Gottschall P.E., Dahl R.R., and Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology 121 (1987) 1580-1582
35. Dunn A.J., and Swiergiel A.H. Behavioral responses to stress are intact in CRF-deficient mice. Brain Res 845 (1999) 14-20
36. Rivest S., and Rivier C. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin. Endocrinology 129 (1991) 2049-2057
37. Kovács K.J., and Elenkov I.J. Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. J Neuroendocrinol 7 (1995) 15-23
38. Ovadia H., Abramsky O., Barak V., Conforti N., Saphier D., and Weidenfeld J. Effect of interleukin-1 on adrenocortical activity in intact and hypothalamic deafferentated male rats. Exp Brain Res 76 (1989) 246-249
39. Saphier D. Neurophysiological and endocrine consequences of immune activity. Psychoneuroendocrinology 14 (1989) 63-87
40. Besedovsky H.O., and del Rey A. Physiological implications of the immune-neuro-endocrine network. In: Ader R., Felten D., and Cohen N. (Eds). Psychoneuroimmunology (1991), Academic Press, New York 589-608
41. Tsagarakis S., Gillies G., Rees L.H., Besser M., and Grossman A. Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology 49 (1989) 98-101
42. Levine S., Berkenbosch F., Suchecki D., and Tilders F.J.H. Pituitary-adrenal and interleukin-6 responses to recombinant interleukin-1 in neonatal rats. Psychoneuroendocrinology 19 (1994) 143-154
43. del Rey A., Furukawa H., Monge-Arditi G., Kabiersch A., Voigt K.-H., and Besedovsky H.O. Alterations in the pituitary-adrenal axis of adult mice following neonatal exposure to interleukin-1. Brain Behav Immun 10 3 (1996) 235-248
44. Dunn A.J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci 43 (1988) 429-435
45. Kabiersch A., del Rey A., Honegger C.G., and Besedovsky H.O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 2 (1988) 267-274
46. Schiltz J.C., and Sawchenko P.E. Signaling the brain in systemic inflammation: The role of perivascular cells. Front Biosci 8 (2003) s1321-s1329
47. Dunn A.J., Wang J.-P., and Ando T. Effects of cytokines on cerebral neurotransmission: Comparison with the effects of stress. Adv Exp Med Biol 461 (1999) 117-127
48. Al-Damluji S. Adrenergic mechanisms in the control of corticotrophin secretion. J Endocrinol 119 (1988) 5-14
49. Plotsky P.M., Cunningham E.T., and Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10 (1989) 437-458
50. Dunn A.J., and Chuluyan H. The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection. Life Sci 51 (1992) 219-225
51. Wieczorek M., and Dunn A.J. Relationships among the behavioral, noradrenergic and pituitary-adrenal responses to interleukin-1 and the effects of indomethacin. Brain Behav Immun 20 (2006) 477-487
52. Rivier C. Influence of immune signals on the hypothalamic-pituitary axis of the rodent. Frontiers Neuroendocrinol 16 (1995) 151-182
53. Chuluyan H., Saphier D., Rohn W.M., and Dunn A.J. Noradrenergic innervation of the hypothalamus participates in the adrenocortical responses to interleukin-1. Neuroendocrinology 56 (1992) 106-111
54. Swiergiel A.H., Dunn A.J., and Stone E.A. The role of cerebral noradrenergic systems in the Fos response to interleukin-1. Brain Res Bull 41 (1996) 61-64
55. Smagin G.N., Swiergiel A.H., and Dunn A.J. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology 21 (1996) 83-93
56. Gaykema R., Dijkstra I., and Tilders F.J.H. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology 136 10 (1995) 4717-4720
57. Kapcala L.P., He J.R., Gao Y., Pieper J.O., and DeTolla L.J. Subdiaphragmatic vagotomy inhibits intra-abdominal interleukin-1β stimulation of adrenocorticotropin secretion. Brain Res 728 (1996) 247-254
58. Dunn A.J., Swiergiel A.H., Zhang H., and Quan N. The hypophagia Induced by interleukin-1 and lipopolysaccharide is associated with induction of cyclooxygenase-2 in brain endothelia. Neuroimmunomodulation 13 (2006) 96-104
59. Wieczorek M., Pournajafi-Nazarloo H., Swiergiel A.H., and Dunn A.J. Physiological and behavioral responses to interleukin-1β and LPS in vagotomized mice. Physiol Behav 84 (2005) 500-511
60. Dunn A.J., Wieczorek M., and Swiergiel A.H. The vagus nerve and cyclooxygenase both participate in interleukin-1-induced activation of brain noradrenergic neurons and the HPA axis in mice and rats. Soc Neurosci Abs 733 (2007) 8
61. Wang J.P., and Dunn A.J. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int 33 (1998) 143-154
62. Silverman M.N., Miller A.H., Biron C.A., and Pearce B.D. Characterization of an interleukin-6 and adrenocorticotropin dependent, immune-to-adrenal pathway during viral infection. Endocrinology 145 (2004) 3580-3589
63. Venihaki M., Dikkes P., Carrigan A., and Karalis K.P. Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 108 (2001) 1159-1166
64. Smith E.M., Tyu H., and Hughes T.K. Interleukin-10 and the hypothalamic-pituitary-adrenal axis. In: Plotnikoff N., Faith R.E., Murgo A.J., and Good R.A. (Eds). Cytokines, Stress and Immunity. 2nd Edn. (2007), CRC Press, Boca Raton, FL 169-192
65. Sharp B.M., Matta S.G., Peterson P.K., Newton R., Chao C., and McAllen K. Tumor necrosis factor-α is a potent ACTH secretagogue: comparison to interleukin-1β. Endocrinology 124 (1989) 3131-3133
66. Ando T., and Dunn A.J. Mouse tumor necrosis factor-α increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice. Neuroimmunomodulation 6 (1999) 319-329
67. Bernardini B., Kamilaris T.C., Calogero A.E., Johnson E.O., Gomez M.T., Gold P.W., et al. Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 126 (1990) 2876-2881
68. Sharp B.M., and Matta S.G. Prostaglandins mediate the adrenocorticotropin response to tumor necrosis factor in rats. Endocrinology 132 (1993) 269-274
69. Cassidy E.M., Manning D., Byrne S., Bolger E., Murray F., Sharifi N., et al. Acute effects of low-dose interferon-alpha on serum cortisol and plasma interleukin-6. J Psychopharmacol 16 (2002) 230-234
70. Blalock J.E., Harbour-McMenamin D., and Smith E.M. Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol 135 (1985) 858-861s
71. Smith E.M., Brosnan P., Meyer W.J., and Blalock J.E. An ACTH receptor on human mononuclear leukocytes. N Engl J Med 317 (1987) 1266-1269
72. Van Woudenberg A.D., Metzelaar M.J., Van Der Kleij A., De Wied D., Burbach J.P.H., and Wiegant V.M. Analysis of proopiomelanocortin (POMC) messenger ribonucleic acid and POMC-derived peptides in human peripheral blood mononuclear cells: no evidence for a lymphocyte-derived POMC system. Endocrinology 133 5 (1993) 1922-1933
73. Sharp B., and Linner K. What do we know about the expression of proopiomelanocortin transcripts and related peptides in lymphoid tissue?. Endocrinology 133 5 (1993) 1921-1922
74. Clarke B.L. Calcium uptake by ACTH-stimulated lymphocytes: what is the physiological significance. Adv Neuroimmunol 5 (1995) 275-281
75. Schäfer M., Carter L., and Stein C. Interleukin 1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91 (1994) 4219-4223
76. Tsagarakis S., and Grossman A. Corticotropin-releasing hormone: interactions with the immune system. Neuroimmunomodulation 1 (1994) 329-334
77. Perrin M.H., and Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885 (1999) 312-328
78. Karalis K., Sano H., Redwine J., Listwak S., Wilder R.L., and Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254 (1991) 421-423
79. Sharp B.M. Multiple opiate receptors on immune cells modulate intracellular signaling. Brain Behav Immun 20 (2006) 9-14
80. Schafer M., Mousa S.A., and Stein C. Corticotropin-releasing factor in antinociception and inflammation. Eur J Pharmacol 323 (1997) 1-10
81. Munck A., and Guyre P. Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol 196 (1986) 81-96
82. Dhabhar F.S., and McEwen B.S. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 11 (1997) 286-306
83. Moynihan J.A. Mechanisms of stress-induced modulation of immunity. Brain Behav Immun 17 (2003) S11-S16
84. Keller S.E., Weiss J.M., Schleifer S.J., Miller N.E., and Stein M. Stress-induced suppression of immunity in adrenalectomized rats. Science 221 (1983) 1301-1304
85. Rabin B.S., Cunnick J.E., and Lysle D.T. Stress-induced alteration of immune function. Prog NeuroEndocrinImmunol 3 (1990) 116-124
86. Keller S.E., Schleifer S.J., Liotta A.S., Bond R.N., Farhoody N., and Stein M. Stress-induced alterations of immunity in hypophysectomized rats. Proc Natl Acad Sci USA 85 (1988) 9297-9301
87. Moynihan J., Kruszewska B., Madden K., and Callahan T. Sympathetic nervous system regulation of immunity. J Neuroimmunol 147 (2004) 87-90